PMID- 31614579
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200928
IS  - 2305-6320 (Print)
IS  - 2305-6320 (Electronic)
IS  - 2305-6320 (Linking)
VI  - 6
IP  - 4
DP  - 2019 Oct 11
TI  - Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: 
      NMB-2017 India Trial.
LID - 10.3390/medicines6040100 [doi]
LID - 100
AB  - Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus 
      (T2DM) resulting in cardio-vascular complications. Yoga practices have shown 
      promising results in alleviating Type 2 Diabetes pathology. Method: In this 
      stratified trial on a Yoga based lifestyle program in cases with Type 2 diabetes, 
      in the rural and urban population from all zones of India, a total of 17,012 
      adults (>20 years) of both genders were screened for lipid profile and sugar 
      levels. Those who satisfied the selection criteria were taught the Diabetes Yoga 
      Protocol (DYP) for three months and the data were analyzed. Results: Among those 
      with Diabetes, 29.1% had elevated total cholesterol (TC > 200 mg/dL) levels that 
      were higher in urban (69%) than rural (31%) Diabetes patients. There was a 
      positive correlation (p = 0.048) between HbA1c and total cholesterol levels. DYP 
      intervention helped in reducing TC from 232.34 +/- 31.48 mg/dL to 189.38 +/- 40.23 
      mg/dL with significant pre post difference (p < 0.001). Conversion rate from high 
      TC (>200 mg/dL) to normal TC (<200 mg/dL) was observed in 60.3% of cases with 
      Type 2 Diabetes Mellitus (T2DM); from high LDL (>130 mg/dL) to normal LDL (<130 
      mg/dL) in 73.7%; from high triglyceride (>200 mg/dL) to normal triglyceride level 
      (<200 mg/dL) in 63%; from low HDL (<45 mg/dL) to normal HDL (>45 mg/dL) in 43.7% 
      of T2DM patients after three months of DYP. Conclusions: A Yoga lifestyle program 
      designed specifically to manage Diabetes helps in reducing the co-morbidity of 
      dyslipidemia in cases of patients with T2DM.
FAU - Nagarathna, Raghuram
AU  - Nagarathna R
AD  - Swami Vivekananda Yoga Research Foundation, Bengaluru 560105, India. 
      rnagaratna@gmail.com.
FAU - Tyagi, Rahul
AU  - Tyagi R
AD  - Neuroscience Research Lab, Department of Neurology, Postgraduate Institute of 
      Medical Education and Research, Chandigarh 160012, India. rahul15tyagi@gmail.com.
FAU - Kaur, Gurkeerat
AU  - Kaur G
AD  - Neuroscience Research Lab, Department of Neurology, Postgraduate Institute of 
      Medical Education and Research, Chandigarh 160012, India. 
      Kaurgurkeerat6@gmail.com.
FAU - Vendan, Vetri
AU  - Vendan V
AD  - Swami Vivekananda Yoga Research Foundation, Bengaluru 560105, India. 
      vetriyoga@gmail.com.
FAU - Acharya, Ishwara N
AU  - Acharya IN
AD  - Director, Central Council for Research in Yoga & Naturopathy (CCRYN), Delhi 
      110058, India. acharyaishwar@gmail.com.
FAU - Anand, Akshay
AU  - Anand A
AD  - Neuroscience Research Lab, Department of Neurology, Postgraduate Institute of 
      Medical Education and Research, Chandigarh 160012, India. 
      akshay1anand@rediffmail.com.
FAU - Singh, Amit
AU  - Singh A
AD  - Swami Vivekananda Yoga Research Foundation, Bengaluru 560105, India. 
      dramits90@gmail.com.
FAU - Nagendra, Hongasandra R
AU  - Nagendra HR
AD  - Swami Vivekananda Yoga Research Foundation, Bengaluru 560105, India. 
      chancellor@svyasa.edu.in.
LA  - eng
GR  - 16-63/2016-17/CCRYN/RES/Y&D/MCT/ Dated: 15.12.2016/Central Council for Research 
      in Yoga & Naturopathy/
PT  - Journal Article
DEP - 20191011
PL  - Switzerland
TA  - Medicines (Basel)
JT  - Medicines (Basel, Switzerland)
JID - 101671069
PMC - PMC6963794
OTO - NOTNLM
OT  - DYP
OT  - T2DM
OT  - diabetes mellitus
OT  - diabetic yoga protocol
OT  - dyslipidemia
COIS- The authors declare no conflict of interest.
EDAT- 2019/10/17 06:00
MHDA- 2019/10/17 06:01
PMCR- 2019/10/11
CRDT- 2019/10/17 06:00
PHST- 2019/08/15 00:00 [received]
PHST- 2019/10/06 00:00 [revised]
PHST- 2019/10/08 00:00 [accepted]
PHST- 2019/10/17 06:00 [entrez]
PHST- 2019/10/17 06:00 [pubmed]
PHST- 2019/10/17 06:01 [medline]
PHST- 2019/10/11 00:00 [pmc-release]
AID - medicines6040100 [pii]
AID - medicines-06-00100 [pii]
AID - 10.3390/medicines6040100 [doi]
PST - epublish
SO  - Medicines (Basel). 2019 Oct 11;6(4):100. doi: 10.3390/medicines6040100.